Skip to main content

UBS Group AG

Position in ITRMF — Iterum Therapeutics plc

CIK 1610520 ZURICH, V8

Position in ITRMF

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$96
-$40,086 QoQ
Shares Held
3,201
-97.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 18 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority Sole 6% Shared 0% None 94%

Common Shares in ITRMF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. ITRMF ranks #543 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ITRMF

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $96 3,201
2025-12-31 $40,182 119,948
2025-09-30 $5,778 8,626
2025-06-30 $8,754 8,799
2025-03-31 $10,699 8,699
2024-12-31 $5,440 3,074
2024-09-30 $1 1
2024-06-30 $1 1
2024-03-31 $18,509 12,019
2023-12-31 $9,749 4,949
2023-06-30 $51 48
2023-03-31 $6 6
2022-12-31 $12,821 15,264
2022-09-30 $13,480 8,321